About Us

We are committed to cancer and haematology research to bring hope to future generations. Through teamwork and interactions with patients, relatives and their carers, we aim to provide novel treatments within a safe, and supportive environment, to make a difference to cancer outcomes.

The EPCTU runs approximately 80 early phase (phase I/II) trials every year.  It is fully integrated with haematology, providing trials for patients with haematological as well as solid tumours.

It is staffed by 3 consultant oncologists: Professor Sarah Blagden, Professor Mark Middleton and Dr Simon Lord, a haematology consultant Dr Graham Collins, 3-5 Clinical Research Fellows, 14 nurses including Sandie Wellman our consultant nurse, support from 6 data managers, 5 trial administrators and an in-house Clinical Trials Unit, OCTO.

There is a sample handling facility co-located on the ward which enables a high sample throughput with record keeping, to demonstrate custodianship of the samples, allowing for quality analysis. A team of research nurses and clinical fellows work across the broad portfolio of studies, providing expertise in patient management and protocol compliance.